APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ephrin Type B Receptor 4

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ephrin Type B Receptor 4 Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchEphrin Type B Receptor 4 Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ephrin Type B Receptor 4 Industry Growth and Trends Forecast to 203260 pages · $3,450 USDMarket StructureGlobal Ephrin Type B Receptor 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ephrin Type B Receptor 4 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Ephrin Type B Receptor 4 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Ephrin Type B Receptor 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ephrin Type B Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ephrin Type B Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ephrin Type B Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ephrin Type B Receptor 4 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ephrin Type B Receptor 4 market include Kadmon Corp LLC, VasGene Therapeutics Inc and Eisai Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ephrin Type B Receptor 4 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ephrin Type B Receptor 4 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ephrin Type B Receptor 4 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ephrin Type B Receptor 4 market.

Ephrin Type B Receptor 4 Segment by Company

Kadmon Corp LLC

VasGene Therapeutics Inc

Eisai Co Ltd

Ephrin Type B Receptor 4 Segment by Type

VDAU-11

Tesevatinib Tosylate

Vas-01

Others

Ephrin Type B Receptor 4 Segment by Application

Solid Tumor

Colorectal Cancer

Melanoma

Bile Duct Cancer

Others

Ephrin Type B Receptor 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ephrin Type B Receptor 4 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ephrin Type B Receptor 4 key companies, revenue, market share, and recent developments.

3. To split the Ephrin Type B Receptor 4 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ephrin Type B Receptor 4 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ephrin Type B Receptor 4 significant trends, drivers, influence factors in global and regions.

6. To analyze Ephrin Type B Receptor 4 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ephrin Type B Receptor 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ephrin Type B Receptor 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ephrin Type B Receptor 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ephrin Type B Receptor 4 industry.

Chapter 3: Detailed analysis of Ephrin Type B Receptor 4 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ephrin Type B Receptor 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ephrin Type B Receptor 4 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ephrin Type B Receptor 4 Industry Trends Table 2. Ephrin Type B Receptor 4 Industry Drivers Table 3. Ephrin Type B Receptor 4 Industry Opportunities and Challenges Table 4. Ephrin Type B Receptor 4 Industry Restraints Table 5. Global Ephrin Type B Receptor 4 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ephrin Type B Receptor 4 Revenue Share by Company (2021-2026) Table 7. Global Ephrin Type B Receptor 4 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ephrin Type B Receptor 4 Key Company Manufacturing Base & Headquarters Table 9. Global Ephrin Type B Receptor 4 Company, Product Type & Application Table 10. Global Ephrin Type B Receptor 4 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ephrin Type B Receptor 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of VDAU-11 Table 15. Significant Companies of Tesevatinib Tosylate Table 16. Significant Companies of Vas-01 Table 17. Significant Companies of Others Table 18. Global Ephrin Type B Receptor 4 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Ephrin Type B Receptor 4 Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Ephrin Type B Receptor 4 Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Ephrin Type B Receptor 4 Sales Value Share by Type (2021-2026) Table 22. Global Ephrin Type B Receptor 4 Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Solid Tumor Table 24. Significant Companies of Colorectal Cancer Table 25. Significant Companies of Melanoma Table 26. Significant Companies of Bile Duct Cancer Table 27. Significant Companies of Others Table 28. Global Ephrin Type B Receptor 4 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Ephrin Type B Receptor 4 Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Ephrin Type B Receptor 4 Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Ephrin Type B Receptor 4 Sales Value Share by Application (2021-2026) Table 32. Global Ephrin Type B Receptor 4 Sales Value Share by Application (2027-2032) Table 33. Global Ephrin Type B Receptor 4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ephrin Type B Receptor 4 Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Ephrin Type B Receptor 4 Sales Value Share by Region (2021-2026) Table 36. Global Ephrin Type B Receptor 4 Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Ephrin Type B Receptor 4 Sales Value Share by Region (2027-2032) Table 38. Global Ephrin Type B Receptor 4 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Ephrin Type B Receptor 4 Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Ephrin Type B Receptor 4 Sales Value Market Share by Country (2021-2026) Table 41. Global Ephrin Type B Receptor 4 Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Ephrin Type B Receptor 4 Sales Value Market Share by Country (2027-2032) Table 43. Kadmon Corp LLC Company Information Table 44. Kadmon Corp LLC Business Overview Table 45. Kadmon Corp LLC Ephrin Type B Receptor 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Kadmon Corp LLC Ephrin Type B Receptor 4 Product Portfolio Table 47. Kadmon Corp LLC Recent Development Table 48. VasGene Therapeutics Inc Company Information Table 49. VasGene Therapeutics Inc Business Overview Table 50. VasGene Therapeutics Inc Ephrin Type B Receptor 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. VasGene Therapeutics Inc Ephrin Type B Receptor 4 Product Portfolio Table 52. VasGene Therapeutics Inc Recent Development Table 53. Eisai Co Ltd Company Information Table 54. Eisai Co Ltd Business Overview Table 55. Eisai Co Ltd Ephrin Type B Receptor 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Eisai Co Ltd Ephrin Type B Receptor 4 Product Portfolio Table 57. Eisai Co Ltd Recent Development Table 58. Research Programs/Design for This Report Table 59. Authors List of This Report Table 60. Secondary Sources Table 61. Primary Sources List of Figures Figure 1. Ephrin Type B Receptor 4 Product Image Figure 2. Global Ephrin Type B Receptor 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ephrin Type B Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 4. Global Ephrin Type B Receptor 4 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. VDAU-11 Image Figure 8. Tesevatinib Tosylate Image Figure 9. Vas-01 Image Figure 10. Others Image Figure 11. Global Ephrin Type B Receptor 4 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Ephrin Type B Receptor 4 Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Ephrin Type B Receptor 4 Sales Value Share by Type (2021-2032) Figure 14. Solid Tumor Image Figure 15. Colorectal Cancer Image Figure 16. Melanoma Image Figure 17. Bile Duct Cancer Image Figure 18. Others Image Figure 19. Global Ephrin Type B Receptor 4 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Ephrin Type B Receptor 4 Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Ephrin Type B Receptor 4 Sales Value Share by Application (2021-2032) Figure 22. Global Ephrin Type B Receptor 4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Ephrin Type B Receptor 4 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Ephrin Type B Receptor 4 Sales Value (2021-2032) & (US$ Million) Figure 25. North America Ephrin Type B Receptor 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Ephrin Type B Receptor 4 Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Ephrin Type B Receptor 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Ephrin Type B Receptor 4 Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Ephrin Type B Receptor 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Ephrin Type B Receptor 4 Sales Value (2021-2032) & (US$ Million) Figure 31. South America Ephrin Type B Receptor 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Ephrin Type B Receptor 4 Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Ephrin Type B Receptor 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • VDAU-11
  • Tesevatinib Tosylate
  • Vas-01
  • Others
Applications
  • Solid Tumor
  • Colorectal Cancer
  • Melanoma
  • Bile Duct Cancer
  • Others
Companies covered
  • Kadmon Corp LLC
  • VasGene Therapeutics Inc
  • Eisai Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ephrin Type B Receptor 4 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ephrin Type B Receptor 4 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ephrin Type B Receptor 4 Market Dynamics
  1. 2.1 Ephrin Type B Receptor 4 Industry Trends
  2. 2.2 Ephrin Type B Receptor 4 Industry Drivers
  3. 2.3 Ephrin Type B Receptor 4 Industry Opportunities and Challenges
  4. 2.4 Ephrin Type B Receptor 4 Industry Restraints
3 Ephrin Type B Receptor 4 Market by Company
  1. 3.1 Global Ephrin Type B Receptor 4 Company Revenue Ranking in 2025
  2. 3.2 Global Ephrin Type B Receptor 4 Revenue by Company (2021-2026)
  3. 3.3 Global Ephrin Type B Receptor 4 Company Ranking (2024-2026)
  4. 3.4 Global Ephrin Type B Receptor 4 Company Manufacturing Base and Headquarters
  5. 3.5 Global Ephrin Type B Receptor 4 Company Product Type and Application
  6. 3.6 Global Ephrin Type B Receptor 4 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ephrin Type B Receptor 4 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ephrin Type B Receptor 4 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ephrin Type B Receptor 4 Market by Type
  1. 4.1 Ephrin Type B Receptor 4 Type Introduction
  2. 4.1.1 VDAU-11
  3. 4.1.2 Tesevatinib Tosylate
  4. 4.1.3 Vas-01
  5. 4.1.4 Others
  6. 4.2 Global Ephrin Type B Receptor 4 Sales Value by Type
  7. 4.2.1 Global Ephrin Type B Receptor 4 Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ephrin Type B Receptor 4 Sales Value by Type (2021-2032)
  9. 4.2.3 Global Ephrin Type B Receptor 4 Sales Value Share by Type (2021-2032)
5 Ephrin Type B Receptor 4 Market by Application
  1. 5.1 Ephrin Type B Receptor 4 Application Introduction
  2. 5.1.1 Solid Tumor
  3. 5.1.2 Colorectal Cancer
  4. 5.1.3 Melanoma
  5. 5.1.4 Bile Duct Cancer
  6. 5.1.5 Others
  7. 5.2 Global Ephrin Type B Receptor 4 Sales Value by Application
  8. 5.2.1 Global Ephrin Type B Receptor 4 Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Ephrin Type B Receptor 4 Sales Value by Application (2021-2032)
  10. 5.2.3 Global Ephrin Type B Receptor 4 Sales Value Share by Application (2021-2032)
6 Ephrin Type B Receptor 4 Regional Value Analysis
  1. 6.1 Global Ephrin Type B Receptor 4 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ephrin Type B Receptor 4 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ephrin Type B Receptor 4 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ephrin Type B Receptor 4 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ephrin Type B Receptor 4 Sales Value (2021-2032)
  7. 6.3.2 North America Ephrin Type B Receptor 4 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ephrin Type B Receptor 4 Sales Value (2021-2032)
  10. 6.4.2 Europe Ephrin Type B Receptor 4 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ephrin Type B Receptor 4 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ephrin Type B Receptor 4 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ephrin Type B Receptor 4 Sales Value (2021-2032)
  16. 6.6.2 South America Ephrin Type B Receptor 4 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ephrin Type B Receptor 4 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ephrin Type B Receptor 4 Sales Value Share by Country, 2025 VS 2032
7 Ephrin Type B Receptor 4 Country-level Value Analysis
  1. 7.1 Global Ephrin Type B Receptor 4 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ephrin Type B Receptor 4 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ephrin Type B Receptor 4 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ephrin Type B Receptor 4 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ephrin Type B Receptor 4 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ephrin Type B Receptor 4 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ephrin Type B Receptor 4 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kadmon Corp LLC
  2. 8.1.1 Kadmon Corp LLC Company Information
  3. 8.1.2 Kadmon Corp LLC Business Overview
  4. 8.1.3 Kadmon Corp LLC Ephrin Type B Receptor 4 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Kadmon Corp LLC Ephrin Type B Receptor 4 Product Portfolio
  6. 8.1.5 Kadmon Corp LLC Recent Developments
  7. 8.2 VasGene Therapeutics Inc
  8. 8.2.1 VasGene Therapeutics Inc Company Information
  9. 8.2.2 VasGene Therapeutics Inc Business Overview
  10. 8.2.3 VasGene Therapeutics Inc Ephrin Type B Receptor 4 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 VasGene Therapeutics Inc Ephrin Type B Receptor 4 Product Portfolio
  12. 8.2.5 VasGene Therapeutics Inc Recent Developments
  13. 8.3 Eisai Co Ltd
  14. 8.3.1 Eisai Co Ltd Company Information
  15. 8.3.2 Eisai Co Ltd Business Overview
  16. 8.3.3 Eisai Co Ltd Ephrin Type B Receptor 4 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eisai Co Ltd Ephrin Type B Receptor 4 Product Portfolio
  18. 8.3.5 Eisai Co Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst